Neutralizing proprotein convertase subtilisin kexin type 9...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/48 (2006.01) A61P 3/06 (2006.01) C12N 9/64 (2006.01)

Patent

CA 2720681

Neutralizing PCSK9 variants that interact with low density lipoprotein receptor (LDLR) are described. Methods and compositions for treating disorders by administering a pharmaceutically effective amount of a neutralizing PCSK9 variant are described.

La présente invention concerne des variants neutralisants de la PCSK9 qui interagissent avec un récepteur de lipoprotéines de faible densité (LDLR). Des méthodes et des compositions permettant de traiter des troubles par administration dune quantité pharmaceutiquement efficace dun variant neutralisant de la PCSK9 sont décrites.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Neutralizing proprotein convertase subtilisin kexin type 9... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Neutralizing proprotein convertase subtilisin kexin type 9..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neutralizing proprotein convertase subtilisin kexin type 9... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1595267

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.